4//SEC Filing
Levitz Michael L 4
Accession 0001171843-24-001304
CIK 0000898437other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:01 PM ET
Size
21.1 KB
Accession
0001171843-24-001304
Insider Transaction Report
Form 4
Levitz Michael L
EVP, CFO, Treasurer
Transactions
- Tax Payment
Common Stock
2024-03-11$25.42/sh−1,303$33,122→ 36,527 total - Exercise/Conversion
Common Stock
2024-03-11+5,875→ 42,402 total - Tax Payment
Common Stock
2024-03-11$25.42/sh−1,725$43,850→ 40,677 total - Exercise/Conversion
Common Stock
2024-03-11+8,888→ 49,565 total - Tax Payment
Common Stock
2024-03-11$25.79/sh−2,610$67,312→ 46,955 total - Exercise/Conversion
Restricted Stock Unit
2024-03-11−4,438→ 0 totalExercise: $0.00→ Common Stock (4,438 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-11−5,875→ 11,749 totalExercise: $0.00→ Common Stock (5,875 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-11−8,888→ 8,888 totalExercise: $0.00→ Common Stock (8,888 underlying) - Exercise/Conversion
Common Stock
2024-03-11+4,438→ 37,830 total
Footnotes (12)
- [F1]Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
- [F10]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
- [F11]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
- [F12]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
- [F2]Includes 160 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.
- [F3]Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
- [F4]Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Reflects the first vesting installment of RSUs granted on March 9, 2023.
- [F6]Reflects an aggregate of 1,725 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
- [F7]Reflects the second vesting installment of RSUs granted on March 11, 2022.
- [F8]Reflects an aggregate of 2,610 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.
- [F9]Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001468019
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 8:01 PM ET
- Size
- 21.1 KB